Which medical product launch was celebrated for reducing stroke risk by over 60% in patients with atrial fibrillation compared to traditional treatment options when introduced to the market?

The pharmaceutical and medical device industries are known for their groundbreaking product launches that have transformed healthcare. These launches often represent years of research, clinical trials, and regulatory hurdles. This trivia tests your knowledge about one of the most significant medical product launches in recent history that changed treatment paradigms and patient outcomes.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Dabigatran (Pradaxa) - the first DOAC (Direct Oral Anticoagulant) approved as an alternative to warfarin
Semaglutide (Ozempic) - the GLP-1 receptor agonist for diabetes management
Adalimumab (Humira) - the TNF inhibitor for autoimmune conditions
Pembrolizumab (Keytruda) - the PD-1 inhibitor immunotherapy for cancer treatment